NovoLog FlexPen and Ranibizumab Intraocular
Determining the interaction of NovoLog FlexPen and Ranibizumab Intraocular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- NovoLog FlexPen-Ranibizumab ophthalmic
- NovoLog FlexPen-Ranitidine
- NovoLog FlexPen-Ranitidine Capsule
- NovoLog FlexPen-Ranitidine Hydrochloride
- NovoLog FlexPen-Ranitidine Injection
- NovoLog FlexPen-Ranitidine Suspension
- Ranibizumab Intraocular-Novolog Injection
- Ranibizumab Intraocular-NovoLog Mix 70/30
- Ranibizumab Intraocular-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens))
- Ranibizumab Intraocular-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Vials))
- Ranibizumab Intraocular-NovoLog Mix 70/30 FlexPen
- Ranibizumab Intraocular-NovoLog PenFill